Abstract |
The current study evaluated the potential anti- colorectal cancer (CRC) activity by Ku-0060648, a novel DNA- PKcs and PI3K duel inhibitor. In both CRC cell lines (HCT-116 and HT-29) and primary human colon cancer cells, Ku-0060648 exposure at nM concentrations efficiently inhibited cell proliferation. Meanwhile, Ku-0060648 provoked apoptosis in CRC cells. Ku-0060648 was yet ineffective to the normal colon epithelial cells. Ku-0060648 blocked PI3K-AKT-mTOR cascade and in-activated DNA- PKcs in CRC cells. Intriguingly, Ku-0060648 treatment induced feedback autophagy activation in HCT-116 cells. On the other hand, pharmacological autophagy inhibitors (3-methyladenine or chloroquine) or silencing key autophagy proteins (Beclin-1 or ATG-7) dramatically potentiated Ku-0060648-induced HCT-116 cell apoptosis. Together, these results suggest that feedback autophagy activation is a key resistance factor of Ku-0060648 in CRC cells, and autophagy inhibition sensitizes Ku-0060648-induced anti-CRC activity.
|
Authors | Mintao Mao, Yumei Liu, Xinhai Gao |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 490
Issue 4
Pg. 1244-1249
(09 02 2017)
ISSN: 1090-2104 [Electronic] United States |
PMID | 28676397
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 Elsevier Inc. All rights reserved. |
Chemical References |
- 2-(4-ethylpiperazin-1-yl)-N-(4-(2-morpholino-4-oxo-4H-chromen-8-yl)dibenzo(b,d)thiophen-1-yl)acetamide
- Antineoplastic Agents
- Chromones
- Thiophenes
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Autophagy
(drug effects)
- Cell Proliferation
(drug effects)
- Chromones
(pharmacology)
- Colorectal Neoplasms
(drug therapy, pathology)
- Drug Screening Assays, Antitumor
- Humans
- Structure-Activity Relationship
- Thiophenes
(pharmacology)
- Tumor Cells, Cultured
|